Arteris (NASDAQ:AIP) Upgraded at Wall Street Zen

Arteris (NASDAQ:AIP) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Monday.

A number of other equities research analysts have also weighed in on the company. Rosenblatt Securities reaffirmed a “buy” rating and issued a $14.00 price objective on shares of Arteris in a report on Wednesday, May 21st. TD Cowen lifted their price objective on Arteris from $12.00 to $15.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of $15.00.

Arteris Stock Down 2.0%

Shares of AIP stock opened at $8.75 on Monday. The stock has a market capitalization of $373.19 million, a PE ratio of -10.67 and a beta of 1.44. Arteris has a 52-week low of $5.46 and a 52-week high of $14.29. The stock’s 50-day moving average price is $9.48 and its 200 day moving average price is $8.20.

Arteris (NASDAQ:AIP) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.11). The firm had revenue of $16.50 million for the quarter, compared to analysts’ expectations of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Analysts expect that Arteris will post -0.73 earnings per share for the current fiscal year.

Insider Buying and Selling at Arteris

In other news, major shareholder Bayview Legacy, Llc sold 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 5th. The stock was sold at an average price of $13.12, for a total transaction of $656,000.00. Following the sale, the insider owned 9,839,071 shares of the company’s stock, valued at $129,088,611.52. The trade was a 0.51% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Laurent R. Moll sold 8,129 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $8.74, for a total value of $71,047.46. Following the sale, the chief operating officer directly owned 386,552 shares in the company, valued at $3,378,464.48. This trade represents a 2.06% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 510,616 shares of company stock worth $5,979,663. Corporate insiders own 33.70% of the company’s stock.

Institutional Investors Weigh In On Arteris

Several institutional investors have recently modified their holdings of AIP. Raymond James Financial Inc. purchased a new stake in shares of Arteris during the 2nd quarter worth approximately $32,000. CWM LLC lifted its stake in Arteris by 4,810.1% in the 1st quarter. CWM LLC now owns 10,213 shares of the company’s stock valued at $71,000 after buying an additional 10,005 shares in the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in Arteris in the 1st quarter valued at approximately $95,000. Savant Capital LLC purchased a new stake in Arteris in the 2nd quarter valued at approximately $97,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in Arteris in the 2nd quarter valued at approximately $104,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.